NASDAQ: ROIV - Roivant Sciences Ltd.

Yield per half year: -13.33%
Dividend yield: 0.00%
Sector: Healthcare

Roivant Sciences Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
1.93 61.47 -96.87% -2.01 -195.91%
P/S 67.13 33.58 99.9%
P/BV 1.3 4.79 -72.89%
P/FCF -10.94 60.06 -118.22%
Ev/Ebitda 0.5431 -17.26 -103.15%
Ev/S 18.76 22.49 -16.58%
Ev/FCF -3.05 67.63 -104.52%
E/P 0.5183 0.0168 2977.41%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
10/10
3453.86 -12.31 -28168.72% 664.68 +419.62%
ROE 122.05 9.39 1199.63%
ROA 90.49 0.1519 59461.63%
ROIC -60.13 7.63 -887.67%
ROS 3484.86 -25.64 -13691.13%
ROCE 61.65 14.76 317.74%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.1159 -3.68 -103.15% -0.1688 -168.68%
Nеt Debt/Ebitda -1.4 -4.07 -65.56%
Debt/Ratio 0.0692 0.199 -65.23%
Debt/Equity 0.0837 1.67 -94.97%
Debt/Net Income 0.1149 10.34 -98.89%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5399 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2331 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.4916 -100%
Average percentage for payments 0.138 43.32 -99.68%
Difference from average difference in sector -0.5399

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
9/10
84.34 76.2 10.68%
Growth impulse Ebitda in 5 years 5037.36 44.75 11156.67%
Growth impulse Net Income in 5 years 262.26 -15.36 -1807.42%
Growth impulse FCF in 5 years -0.0065 -9.39 -99.93%
Growth impulse EPS in 5 years -6.05 -84.03 -92.8%
IP Score
6.45/10

Similar companies

IDEXX

Gilead Sciences

Keurig Green Mountain

AstraZeneca PLC

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription